Lenalidomide therapy in del(5)(q31)-associated myelofibrosis: cytogenetic and JAK2V617F molecular remissions (Q80220582)
Jump to navigation
Jump to search
scientific article published on 26 April 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Lenalidomide therapy in del(5)(q31)-associated myelofibrosis: cytogenetic and JAK2V617F molecular remissions |
scientific article published on 26 April 2007 |
Statements
Lenalidomide therapy in del(5)(q31)-associated myelofibrosis: cytogenetic and JAK2V617F molecular remissions (English)
Tefferi A
Lasho TL
Mesa RA
Pardanani A